| 10774085 |
Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds |
Steven W. Andrews, Yutong Jiang, Gan Zhang |
2020-09-15 |
| 10758542 |
Substituted pyrazolo[l,5-a]pyrimidine compounds as Trk kinase inhibitors |
Shelley Allen, Steven W. Andrews, Kevin Ronald Condroski, Lily Huang, Yutong Jiang +2 more |
2020-09-01 |
| 10688100 |
Macrocylic compounds as ROS1 kinase inhibitors |
Steven W. Andrews, James F. Blake, Gabrielle R. Kolakowski |
2020-06-23 |
| 10647730 |
Macrocyclic compounds as TRK kinase inhibitors |
Steven W. Andrews, Kevin Ronald Condroski, Yutong Jiang, Gabrielle R. Kolakowski, Jeongbeob Seo +2 more |
2020-05-12 |
| 10647715 |
KRas G12C inhibitors |
Matthew Arnold Marx, Thomas P. Bobinski, Aaron Craig Burns, John Gaudino, John Michael Ketcham +5 more |
2020-05-12 |
| 10590139 |
Method of treatment using substituted imidazo[1,2b]pyridazine compounds |
Steven W. Andrews, Yutong Jiang, Gan Zhang |
2020-03-17 |
| 10584124 |
Crystalline forms |
Andrew T. Metcalf, David Philip Fry, Elizabeth A. McFaddin, Gabrielle R. Kolakowski, Tony P. Tang +1 more |
2020-03-10 |
| 10555944 |
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors |
Steven W. Andrews, Sean Aronow, James F. Blake, Barbara J. Brandhuber, Adam Cook +9 more |
2020-02-11 |